Detection of Oxacillin (Methicillin)-resistant Staphylococcus aureus Isolated from a Tertiary-care Hospital, Georgetown, Guyana

Main Article Content

Paul Cheddie
Drovashti Seepersaud
Tereasia Ramlochan


Background and Aim: Methicillin-resistant Staphylocccus aureus (MRSA) continues to be a major problem globally. Previous data had suggested that the prevalence of MRSA infections in the tertiary hospital setting was 51%. The aim of this study was to conduct a point prevalence survey of MRSA infections occurring at a tertiary-care hospital in Georgetown, Guyana, and to determine to what extent methicillin-resistance was occurring among Staphylococcus aureus isolates utilising the minimum inhibitory concentration (MIC) data.

Study Design: This study was based on a prospective, analytical design.

Place and Duration of Study: Microbiology department, Georgetown Public Hospital Corporation (GPHC), and Department of Medical Technology, University of Guyana, between May 2019 and July 2019.

Methodology: A total of 101 consecutive, non-repetitive, laboratory-identified MRSA and methicillin-susceptible Staphylococcus aureus (MSSA) isolates were tested using an oxacillin broth microdilution method.

Results: We found that 65.4% of Staphylococcus aureus were oxacillin (methicillin) resistant with a majority of the isolates being high level oxacillin resistant strains (i.e., MICs > 256 μg/ml) (84.85%). Most of the resistant isolates were collected from patients admitted to medical and surgical wards. Conclusion: Methicillin-resistance continues to be a major problem in the hospital setting and conventional techniques are unlikely to identify all of the potentially resistant isolates.

Methicillin-resistant Staphylococcus aureus, MRSA, MSSA, broth microdilution, Guyana.

Article Details

How to Cite
Cheddie, P., Seepersaud, D., & Ramlochan, T. (2020). Detection of Oxacillin (Methicillin)-resistant Staphylococcus aureus Isolated from a Tertiary-care Hospital, Georgetown, Guyana. Microbiology Research Journal International, 29(6), 1-7.
Original Research Article


Llarrull LI, Fisher JF, Mobashery S. Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new β-Lactams that meet the challenge. Antimicrob Agents Chemother. 2009;53(10):4051-4063.

Gajdács M. The continuing threat of methicillin-resistant Staphylococcus aureus. Antibiotics. 2019;8(2):52.

Mylotte JM, McDermott C, Spooner JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis. 1987;9(5):891-907.

Chambers HF. The changing epidemiology of Staphylococcus aureus? Emer Infect Dis. 2001;7(2):178-182.

Nübel U, Roumagnac P, Feldkamp M, Song JH, Ko KS, Huang YC, Coombs G, Ip M, Westh H, Skov R, Struelens MJ, Goering RV, Strommenger B, Weller A, Witte W, Achtman M. Frequent emergence and limited geographic dispersal of methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA. 2008; 105(37):14130-14135.

Rammelkamp CH, Maxon T. Resistance of Staphylococcus aureus to the Action of Penicillin. Proc Royal Soc Exper Biol Med. 1942;51(3):386–389.

Stapleton PD, Taylor PW. Methicillin resistance in Staphylococcus aureus: mechanisms and modulation. Sci Prog. 2002;85(Pt 1):57-72.

Stryjewski ME, Corey GR. Methicillin-resistant Staphylococcus aureus: An Evolving Pathogen. Clin Infect Dis. 2014; 58(S1):S10-S19.

Sit PS, Teh CS, Idris N, Sam IC, Syed Omar SF, Sulaiman H, Thong KL, Kamarulzaman A, Ponnampalavanar S. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infection and the molecular characteristics of MRSA bacteraemia over a two-year period in a tertiary teaching hospital in Malaysia. BMC Infect Dis. 2017;17(1):274.

Determination of Minimum Inhibitory Concentrations (MICs) of antibacterial agents by broth dilution. Eur Soc Clinl Microbiol Infect Dis. 2003;9(8).

Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing M100-S28. 28th Ed. Wayne, Pennsylvania: Clinical and Labora-tory Standards Institute; 2018.

Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically M07-A10. 10th ed. Wayne, Pennsylvania: Clinical and Laboratory Standards Institute; 2015.

Elshikh M, Ahmed S, Funston S, Dunlop P, McGaw M, Marchant R, Banat IM. Resazurin-based 96-well plate micro-dilution method for the determination of minimum inhibitory concentration of bio-surfactants. Biotechnol Lett. 2016;38(6): 1015-9.

Foerster S, Desilvestro V, Hathaway LJ, Althaus CL, Unemo M. A new rapid resazurin-based microdilution assay for antimicrobial susceptibility testing of Neisseria gonorrhoeae. J Antimicrob Chemother. 2017;72(7):1961-1968.

Dozois A, Thomsen I, Jimenez-Truque N. Prevalence and molecular characteristics of methicillin-resistant Staphylococcus aureus among skin and soft tissue infections in an emergency department in Guyana. Emerg Med Jour. 2015;32(10): 800-803.

Reyes J, Rincón S, Díaz L, Panesso D, Contreras GA, Zurita J, Carrillo C, Rizzi A, Guzmán M, Adachi J, Chowdhury S, Murray BE, Arias CA. Dissemination of methicillin-resistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America. Clin Infect Dis. 2009;49(12): 1861-1867.

Arias CA, Reyes J, Caravjal LP, Rincon S, Diaz L, Panesso D, Ibarra G, Rios R, Munita JM, Salles MJ, Alvarez-Moreno C, Labarca J, Garcia C, Luna CM, Mejia-Villatoro C, Zurita J, Guzman-Blanco M, Rodriguez-Noriega E, Narechania A, Rojas LJ, Planet PJ, Weinstock G M, Gotuzzo E, Seas C. A prospective cohort multicenter study of molecular epidemiology and phylogenomics of Staphylococcus aureus bacteremia in nine latin American Countries. Antimicrob Agents Chemother. 2017;61(10):e00816-e00817.

Guardabassi L, Moodley A, Williams A, Stegger M, Damborg P, Halliday-Simmonds I, Butaye P. High prevalence of USA300 among clinical isolates of Methicillin-Resistant Staphylococcus aureus on St. Kitts and Nevis, West Indies. Front Microbiol. 2019;10:1123.

Ramdass M, Balliram S, A C, Bhaggan N, Mohammed B, Singh R, Maharaj J, Boodram A. Prevalence of methicillin-resistant Staphylococcus aureus in the surgical wards of the port-of-Spain general hospital, Trinidad and Tobago. West Indian Med J. 2018;67(1):57-59.

Adhikari R, Pant ND, Neupane S, Neupane M, Bhattarai R, Bhatta S, Chaudhary R, Lekhak B. Detection of Methicillin Resistant Staphylococcus aureus and Determination of Minimum Inhibitory Concentration of Vancomycin for Staphylococcus aureus isolated from pus/wound swab samples of the patients attending a Tertiary Care Hospital in Kathmandu, Nepal. Can J Infect Dis Med Microbiol. 2017;2017:2191532.

Shrestha B, Pokhrel BM, Mohapatra TM. Phenotypic characterization of nosocomial isolates of Staphylococcus aureus with reference to MRSA. J Infect Dev Ctries. 2009;3(7):554-560.

Kshetry AO, Pant ND, Bhandari R, Khatri S, Shrestha KL, Upadhaya SK, Poudel A, Lekhak B, Raghubanshi BR. Minimum inhibitory concentration of vancomycin to methicillin resistant Staphylococcus aureus isolated from different clinical samples at a tertiary care hospital in Nepal. Antimicrob Resist Infect Control. 2016;5:27.

Farahani A, Mohajeri P, Gholamine B, Rezaei M, Abbasi H. Comparison of different phenotypic and genotypic methods for the detection of methicillin-resistant Staphylococcus aureus. N Am J Med Sci. 2013;5(11):637-640.

Paterson GK, Harrison EM, Holmes MA. The emergence of mecC methicillin-resistant Staphylococcus aureus. Trends Microbiol. 2014;22(1):42-47.

Chen FJ, Wang CH, Chen CY, Hsu YC, Wang KT. Role of the mecA gene in oxacillin resistance in a Staphylococcus aureus clinical strain with a pvl-positive ST59 genetic background. Antimicrob Agents Chemother. 2014;58(2):1047–1054.

Alvarez C, Labarca J, Salles M. Prevention strategies for methicillin-resistant Staphylococcus aureus (MRSA) in Latin America. Braz J Infect Dis. 2010;14(Suppl 2):S107-S118.

Srinivasan S, Sheela D, Shashikala, Mathew R, Bazroy J, Kanungo R. Risk factors and associated problems in the management of infections with methicillin resistant Staphylococcus aureus. Indian J Med Microbiol. 2006;24:3.

Calfee DP, Milstone AM, Harris AD, Salgado CD. Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals. Infect Control Hosp Epidemiol. 2014;35(7):772-796.

Hassoun A, Linden PK, Friedman B. Incidence, prevalence and management of MRSA bacteremia across patient populations-a review of recent develop-ments in MRSA management and treatment. Crit Care. 2017;21:211.

Marimuthu K, Pittet D, Harbarth S. The effect of improved hand hygiene on nosocomial MRSA control. Antimicrob Resist Infect Control. 2014;3:34.